46 articles
Raymond Douglas, an oculoplastic surgeon, discusses the approval of TEPEZZA™ (teprotumumab-trbw) for the treatment of Thyroid Eye Disease (TED), the f...
Gustavo Alva, psychiatrist, discusses mood episodes, such as depression, mixed episodes, and mania, why diagnosing bi-polar disorder remains challenging...
Returning guest, President, and CEO of the Muscular Dystrophy Association (MDA), Lynn O’Connor Vos, discusses highlights from the Clinical and Scienti...
Jens Hillengass of Roswell Park Comprehensive Cancer Center, discusses the newly FDA approved immunotherapy combination, Empliciti® (elotuzumab), to tr...
The Crohn’s & Colitis Foundation and the Patient-Centered Outcomes Research Institute (PCORI) have a brand new clinical research study called DINE-CD.
Michael Polydefkis discusses hereditary ATTR amyloidosis and the recently FDA-approved Alnylam's ONPATTRO™, which is the first and only treatment appr...
Jordan Vivian talks about her life as a medical student and spreads the word about the upcoming AMSA Rural Health Summit 2018, a national event designed...
A significant discovery on how Plasmodium falciparum (the parasite that causes malaria) moves fast to avoid getting caught by the immune cells has been ...
A new treatment for primary axillary hyperhidrosis called Qbrexza (glycopyrronium) has been approved by the US Food And Drug Administration (FDA).
Imogen Hines, Sponsorship Officer of AMSA Rural Health Committee, joins Health Professional Radio to promote the upcoming Rural Health Summit in Albury ...